EPHA2, a promising therapeutic target for hepatocellular carcinoma. Journal Article

Local Library Link: Find It @ Loyola

Authors: Wang, H; Qiu, W
Article Title: EPHA2, a promising therapeutic target for hepatocellular carcinoma.
Abstract: Identifying critical drivers of oncogenesis and tumor progression is essential for developing effective hepatocellular carcinoma (HCC) therapeutics. Our recent findings has demonstrated that targeting Ephrin Receptor A2 (EPHA2) suppresses HCC initiation and progression by dual inhibition of the Protein Kinase B (AKT) and Signal Transducer and Activator of Transcription 3 (STAT3) signaling.
Journal Title: Molecular cellular oncology
Publisher: Unknown  
Date Published: 2021